MIRA INFORM REPORT

 

 

Report No. :

510846

Report Date :

24.05.2018

 

 

 

IDENTIFICATION DETAILS

 

Name :

ANM PHARMA PRIVATE LIMITED

 

 

Registered Office :

236, Okhla Industrial Estate, Phase-III, New Delhi - 110020

Tel. No.:

91-11-46541427/ 46545000/ 47476600

 

 

Country :

India

 

 

Financials (as on) :

31.03.2017

 

 

Date of Incorporation :

24.12.2013

 

 

Com. Reg. No.:

55-262682

 

 

Capital Investment / Paid-up Capital :

INR 23.106 Million

 

 

CIN No.:

[Company Identification No.]

U24233DL2013PTC262682

 

 

IEC No.:

[Import-Export Code No.]

0513089489

 

 

TIN No.:

27561066834

 

 

PAN No.:

[Permanent Account No.]

AAMCA3250H

 

 

GSTN :

[Goods & Service Tax Registration No.]

Not Divulged

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Divulged

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

The company is engaged in the trading of pharmaceutical and related drugs (Registered Activity)

 

 

No. of Employees :

Not Divulged

 

 

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January 2017)

 

MIRA’s Rating :

A

 

Credit Rating

Explanation

Rating Comments

A

Acceptable Risk

Business dealings permissible with moderate risk of default

 

Maximum Credit Limit :

USD 116000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually correct

 

 

Litigation :

Clear

 

 

Comments :

ANM Pharma Private Limited is jointly promoted by three major companies namely Mankind Pharma Limited (MPL) 34%, ABS Mercantiles Private Limited (ABS) 33% and Nischem International Private Limited (NIPL) 33%.


The company was incorporated in the year 2013. It is engaged in trading, importing & marketing of Active pharmaceutical ingredients (API) & its intermediaries (Information gathered from other sources).


For the financial year 2017, the revenue of the company has increased by 7.54% along with low profit margin of 0.99%.


The moderate financial profile of the company is marked by low reserve base as compared to its capital.


However, rating weakness is partially offset by subject’s debt free balance sheet profile.

Rating takes into consideration strong financial and managerial support that the company receives from major shareholders backed by its well experienced management team.


Business is active. Payment seems to be usually correct.


In view of aforesaid, the company can be considered for business dealings at usual trade terms and conditions.

 

(Note: As per the Government Registry Record, the address of the company shown as 208, Okhla Industrial Estate, Phase-III, New Delhi – 110020, India.

 

However, management of the company has informed that since company’s establishment they are operating from 236, Okhla Industrial Estate, Phase-III, New Delhi – 110020, India. Further the management also informed us that they are not aware about the block number 208.)

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List

 

Country Name

Previous Rating

(30.09.2017)

Current Rating

(31.12.2017)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderately Low Risk

 

B1

Moderate Risk

 

B2

Moderately High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CARE

Rating

Long term bank facilities : AA

Rating Explanation

High degree of safety and very low credit risk

Date

02.04.2018

 

Rating Agency Name

CARE

Rating

Short term bank facilities : A1+

Rating Explanation

Very strong degree of safety and carry lowest credit risk

Date

02.04.2018

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2018.

 

BIFR (Board for Industrial & Financial Reconstruction) LISTING STATUS

 

Subject’s name is not listed as a Sick Unit in the publicly available BIFR (Board for Industrial & Financial Reconstruction) list as of 24.05.2018

 

IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS

 

Subject’s name is not listed in the publicly available IBBI (Insolvency and Bankruptcy Board of India) list as of report date.

 

INFORMATION DECLINED

 

Management non-cooperative (Tel No.: 91-22-22634141/ 91-11-46541427/ 46545000)

 

LOCATIONS

 

Registered Office :

236, Okhla Industrial Estate, Phase-III, New Delhi – 110020, India

Tel. No.:

91-11-46541427/ 46545000/ 47476600

Fax No.:

Not Available

E-Mail :

secretarial.mkd@gmai.com

info@anmpharma.com

Website :

http://www.anmpharma.com

Locality :

Industrial

 

 

Warehouse:

Building No-L, Gala No.1, Ground Floor, Shree Munisuvarat Complex, Survey No.120, Hiss No.1, Anjur Phata, Rahnal Village, Taluka Bhiwandi-15, Thane Z5 – 421302, Maharashtra, India

 

Admin. Office (West) / Sales Depot:

3, Botawala Building, Ground Floor and 1st Floor, Nyayamurthi G. N. Vaidya Marg, Behind State Bank of India, Fort, Mumbai – 400023, Maharashtra, India 

Tel. No.:

91-22-22634141

 

Admin. Office (North)

C-980, Sushant Lok, Phase-1, Gurugram - 122002, Haryana, India

 

 

DIRECTORS

 

As on 31.03.2017

 

Name :

Mr. Anshul Sikri

Designation :

Director

Address :

C-976, Sushant Lok, Phase-1, Gurugram - 122002, Haryana, India

Date of Birth/Age :

02.05.1984

Qualification :

Graduate

Date of Appointment :

15.10.2014

PAN No.:

BAUPS9363R

DIN No.:

00448268

Other Directorship:

CIN/FCRN

Company Name

Begin Date

End Date

U24110TG1988PLC008392

S B ORGANICS LIMITED

29/04/2015

-

U24110TG1988PLC008392

S B ORGANICS LIMITED

30/09/2015

-

U85199DL2003PTC120991

DAZZLING GROOMING SERVICES PRIVATE LIMITED

19/06/2003

-

U74999DL2011PLC224400

VAXER PHARMA LIMITED

30/08/2011

-

U74140HR2015PTC056381

TIGER ROAR HEALTHCARE PRIVATE LIMITED

11/08/2015

-

 

 

Name :

Mr. Bharat Balubhai Shah

Designation :

Director

Address :

90/11, Marine Drive, Neeta Building, 3rd Floor, Mumbai - 400002, Maharashtra, India

Date of Birth/Age :

05.05.1938

Date of Appointment :

15.10.2014

PAN No.:

AABPS6296F

DIN No.:

02181279

 

 

Name :

Ms. Nidhi Arora

Designation :

Director

Address :

A-1/9, Poorvi Marg, Vasant Vihar, New Delhi - 110057, India

Date of Birth/Age :

23.02.1978

Qualification :

Graduate

Date of Appointment :

15.10.2014

PAN No.:

AGLPA9177D

DIN No.:

06754250

Other Directorship:

CIN/FCRN

Company Name

Begin Date

End Date

U67120DL1996PTC078045

CASABLANCA SECURITIES PRIVATE LIMITED

23/09/2014

-

U45201DL2005PTC132765

INDU BUILDWELL PRIVATE LIMITED

29/09/2016

-

U45202UP2014PTC064163

INDER BUILDWELL PRIVATE LIMITED

30/09/2016

-

 

 

MAJOR SHAREHOLDERS

 

As on 31.03.2017

 

Names of Shareholders

No. of Shares

% of Holding

ABS Mercantiles Private Limited, India

762500

33.00

Nischem International Private Limited, India

762500

33.00

Mankind Pharma Limited, India

785606

34.00

Total

2310606

100.00

 

 


Equity Share Break up (Percentage of Total Equity)

 

As on 28.09.2017

 

Category

Percentage

Promoters (Body corporate)

100.00

Total 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

The company is engaged in the trading of pharmaceutical and related drugs (Registered Activity)

 

 

Products / Services :

Item Code No.

Products/Services Description

99611730

Pharmaceutical products

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Divulged 

 

 

Imports :

Not Divulged 

 

 

Terms :

Not Divulged 

 

PRODUCTION STATUS – (NOT AVAILABLE)

 

 

GENERAL INFORMATION

 

Suppliers :

 

Reference :

Not Divulged

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark:

--

 

 

Customers :

 

Reference :

Not Divulged

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark:

--

 

 

No. of Employees :

Not Divulged

 

 

Bankers (As on 2016) :

Banker Name :

IDFC Bank Limited

Branch :

KRM Tower, 8th Floor, No. 1, Harrington Road, Chetpet Chennai-600031, Tamilnadu, India

Person Name (With Designation) :

--

Contact Number :

--

Name of Account Holder :

--

Account Number :

--

Account Since (Date/Year of Account Opening) :

--

Average Balance Maintained :

--

Credit Facilities Enjoyed (CC/OD/Term Loan) :

--

Account Operation :

--

Remark :

--

 

Auditors :

 

Name :

Bhagi Bhardwaj Gaur and Company

Chartered Accountants

Address :

2952-53/2, Sangatrashan, D.B. Gupta Road, Pahar Ganj, New Delhi, India

Income-tax PAN of auditor or auditor's firm :

AADFB8409K

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Associates :

·         Mankind Pharma Limited

CIN No.: U74899DL1991PLC044843

·         ABS Mercantiles Private Limited

CIN No.:U24231DL1997PTC086948

·         Nischem International Private Limited

 

 

Enterprises over which KMP & their relatives severally or jointly exercise significant influence:

·         Copmed Pharmaceuticals Private Limited

·         Mankind Specialities

·         Pharma Force Lab

·         Relax Pharmaceuticals Private Limited

·         Next Wave India

·         JK Print Pack

·         Penta Biotech

·         Abil Chempharma Private Limited

 

CAPITAL STRUCTURE

 

As on 28.09.2017

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

3000000

Equity Shares

INR 10/- each

INR 30.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

2310606

Equity Shares

INR 10/- each

INR 23.106 Million

 

 

 

 

 


 

FINANCIAL DATA

[all figures are INR Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

31.03.2017

31.03.2016

31.03.2015

 

 

 

 

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

23.106

23.106

23.106

(b) Reserves & Surplus

17.662

4.904

3.821

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

40.768

28.010

26.927

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

0.000

0.000

0.000

(b) Deferred tax liabilities (Net)

0.165

0.000

0.000

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

0.165

0.000

0.000

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

0.000

0.000

10.460

(b) Trade payables

289.275

231.705

227.396

(c) Other current liabilities

76.804

62.458

3.283

(d) Short-term provisions

0.000

0.000

1.759

Total Current Liabilities (4)

366.079

294.163

242.898

 

 

 

 

TOTAL

407.012

322.173

269.825

 

 

 

 

II.          ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

5.903

0.132

0.106

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Capital work-in-progress

0.000

0.000

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

0.000

0.009

0.002

(d)  Long-term Loan and Advances

0.000

0.000

0.049

(e) Other Non-current assets

0.025

0.944

0.000

Total Non-Current Assets

5.928

1.085

0.157

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

119.968

53.439

10.465

(c) Trade receivables

258.819

238.352

234.411

(d) Cash and cash equivalents

2.082

1.614

0.132

(e) Short-term loans and advances

0.000

0.000

0.000

(f) Other current assets

20.215

27.683

24.660

Total Current Assets

401.084

321.088

269.668

 

 

 

 

TOTAL

407.012

322.173

269.825

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2017

31.03.2016

31.03.2015

 

SALES

 

 

 

 

Income

1287.912

1197.582

589.556

 

Other Income

15.046

3.039

2.634

 

TOTAL

1302.958

1200.621

592.190

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Purchases of Stock-in-Trade

1236.931

1180.513

581.352

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

(0.752)

(33.986)

(10.465)

 

Employees benefits expense

0.695

1.107

1.891

 

Other expenses

35.627

45.917

11.285

 

TOTAL

1272.501

1193.551

584.063

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

30.457

7.070

8.127

 

 

 

 

 

Less

FINANCIAL EXPENSES

10.635

5.410

0.408

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

19.822

1.660

7.719

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION

0.087

0.048

0.022

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

19.735

1.612

7.697

 

 

 

 

 

Less

TAX

6.978

0.529

1.757

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX 

12.757

1.083

5.940

 

 

 

 

 

 

Earnings / (Loss) Per Share (INR)

5.52

0.47

3.98

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2017

31.03.2016

31.03.2015

Current Maturities of Long term debt

NA

NA

NA

Cash generated from operations

NA

NA

NA

Net cash flows from (used in) operations

13.533

5.125

(22.183)

 

 

KEY RATIOS

 

EFFICIENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Average Collection Days

(Sundry Debtors / Income * 365 Days)

73.35

72.65

145.13

 

 

 

 

Account Receivables Turnover

(Income / Sundry Debtors)

4.98

5.02

2.52

 

 

 

 

Average Payment Days

(Sundry Creditors / Purchases * 365 Days)

85.36

71.64

142.77

 

 

 

 

Inventory Turnover

(Operating Income / Inventories)

0.25

0.13

0.78

 

 

 

 

Asset Turnover

(Operating Income / Net Fixed Assets)

5.16

53.56

76.67

 

 

LEVERAGE RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Debt Ratio

((Borrowing + Current Liabilities) / Total Assets)

0.90

0.91

0.90

 

 

 

 

Debt Equity Ratio

(Total Liability / Networth)

0.00

0.00

0.39

 

 

 

 

Current Liabilities to Networth

(Current Liabilities / Net Worth)

8.98

10.50

9.02

 

 

 

 

Fixed Assets to Networth

(Net Fixed Assets / Networth)

0.14

0.00

0.00

 

 

 

 

Interest Coverage Ratio

(PBIT / Financial Charges)

2.86

1.31

19.92

 

 

PROFITABILITY RATIOS

 

PARTICULARS

 

 

31.03.2017

31.03.2016

31.03.2015

Net Profit Margin

((PAT / Sales) * 100)

%

0.99

0.09

1.01

 

 

 

 

 

Return on Total Assets

((PAT / Total Assets) * 100)

%

3.13

0.34

2.20

 

 

 

 

 

Return on Investment (ROI)

((PAT / Networth) * 100)

%

31.29

3.87

22.06

 

 

SOLVENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Current Ratio

(Current Assets / Current Liabilities)

1.10

1.09

1.11

 

 

 

 

Quick Ratio

((Current Assets – Inventories) / Current Liabilities)

0.77

0.91

1.07

 

 

 

 

G-Score Ratio Financial

(Networth / Total Assets)

0.10

0.09

0.10

 

 

 

 

G-Score Ratio Debt

(Debts / Equity Capital)

0.00

0.00

0.45

 

 

 

 

G-Score Ratio Liquidity

(Total Current Assets / Total Current Liabilities)

1.10

1.09

1.11

 

Total Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term debts

 

 


 

FINANCIAL ANALYSIS

[all figures are in INR Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2015

31.03.2016

31.03.2017

 

INR In Million

INR In Million

INR In Million

Share Capital

23.106

23.106

23.106

Reserves & Surplus

3.821

4.904

17.662

Net worth

26.927

28.010

40.768

 

 

 

 

long-term borrowings

0.000

0.000

0.000

Short term borrowings

10.460

0.000

0.000

Total borrowings

10.460

0.000

0.000

Debt/Equity ratio

0.388

0.000

0.000

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2015

31.03.2016

31.03.2017

 

INR In Million

INR In Million

INR In Million

Sales

589.556

1197.582

1287.912

 

 

103.133

7.543

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2015

31.03.2016

31.03.2017

 

INR In Million

INR In Million

INR In Million

Sales

589.556

1197.582

1287.912

Profit

5.940

1.083

12.757

 

1.01%

0.09%

0.99%

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of establishment

Yes

2]

Constitution of the entity Incorporation details

Yes

3]

Locality of the entity

Yes

4]

Premises details

No

5]

Buyer visit details

--

6]

Contact numbers

Yes

7]

Name of the person contacted

No

8]

Designation of contact person

No

9]

Promoter’s background

Yes

10]

Date of Birth of Proprietor / Partners / Directors

Yes

11]

Pan Card No. of Proprietor / Partners

No

12]

Voter Id Card No. of Proprietor / Partners

No

13]

Type of business

Yes

14]

Line of Business

Yes

15]

Export/import details (if applicable)

No

16]

No. of employees

No

17]

Details of sister concerns

Yes

18]

Major suppliers

No

19]

Major customers

No

20]

Banking Details

Yes

21]

Banking facility details

Yes

22]

Conduct of the banking account

--

23]

Financials, if provided

Yes

24]

Capital in the business

Yes

25]

Last accounts filed at ROC, if applicable

Yes

26]

Turnover of firm for last three years

Yes

27]

Reasons for variation <> 20%

--

28]

Estimation for coming financial year

No

29]

Profitability for last three years

Yes

30]

Major shareholders, if available

Yes

31]

External Agency Rating, if available

Yes

32]

Litigations that the firm/promoter involved in

--

33]

Market information

--

34]

Payments terms

No

35]

Negative Reporting by Auditors in the Annual Report

No

 

CORPORATE INFORMATION

 

The Company was incorporated on 24 Dec 2013 it is a associate company of Mankind Pharma Limited. The company is engaged in the trading of pharmaceutical and related drugs in India.

 

SUMMARY OF OPERATIONS

 

During the year, the net profit of The Company has increased significantly from INR 1.083 million to Rs. 12.757 million

 

INDEX OF CHARGES

 

S

No

SRN

Charge Id

Charge Holder Name

Date of Creation

Date of Modification

Amount

Address

1

G01315373

100019791

IDFC BANK LIMITED

02/02/2016

-

650000000.0

KRM TOWER, 8TH FLOOR, NO. 1,HARRINGTON ROAD, CHETPET CHENNAI TAMILNADU 600031 INDIA

2

C52337714

10494439

YES BANK LIMITED

13/02/2014

24/03/2015

500000000.0

9TH FLOOR, NEHRU CENTRE, DISCOVERY OF INDIA, DR. ANNIE BESANT ROAD, WORLI, MUMBAI MAHARASHTRA 400018 INDIA

 

 

 

FIXED ASSETS

 

  • Plant and equipment
  • Furniture and fixtures
  • Vehicles
  • Computer equipments
  • Office equipment
  • Motor vehicles

 

 

 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

INR

US Dollar

1

INR 68.02

UK Pound

1

INR 91.25

Euro

1

INR 80.07

 

 

INFORMATION DETAILS

 

Information Gathered by :

AKS

 

 

Analysis Done by :

VAR

 

 

Report Prepared by :

JYTK

 


 

SCORE FACTORS

 

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

 

RATING EXPLANATIONS

 

Credit Rating

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

A+

Low Risk

Business dealings permissible with low risk of default

A

Acceptable Risk

Business dealings permissible with moderate risk of default

B

Medium Risk

Business dealings permissible on a regular monitoring basis

C

Medium High Risk

Business dealings permissible preferably on secured basis

D

High Risk

Business dealing not recommended or on secured terms only

NB

New Business

No recommendation can be done due to business in infancy stage

NT

No Trace

No recommendation can be done as the business is not traceable

 

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

 

·         Financial condition covering various ratios

·         Company background and operations size

·         Promoters / Management background

·         Payment record

·         Litigation against the subject

·         Industry scenario / competitor analysis

·         Supplier / Customer / Banker review (wherever available)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.